VEGFA Antikörper (Isoform 6)
Kurzübersicht für VEGFA Antikörper (Isoform 6) (ABIN6254198)
Target
Alle VEGFA Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- Isoform 6
-
Verwendungszweck
- Anti-VEGFA
-
Sequenz
- MNFLLSWVHW SLALLLYLHH AKWSQAAPMA EGGGQNHHEV VKFMDVYQRS YCHPIETLVD IFQEYPDEIE YIFKPSCVPL MRCGGCCNDE GLECVPTEES NITMQIMRIK PHQGQHIGEM SFLQHNKCEC RPKKDRARQE KCDKPRR
-
Spezifität
- Detects endogenous levels of total VEGFA by Western blot in whole cell and tissue lysates.
-
Produktmerkmale
- Vascular endothelial growth factor A
-
Aufreinigung
- Epitope affinity purified
-
Immunogen
- Purified recombinant human VEGFA isoform 6 produced in E. coli.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- WB:1:250-1:2,000, IF:1:50-1:250
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Buffer
- PBS, 20 % glycerol and 0.05 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- The antibody solution should be gently mixed before use.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- For continuous use, store at 2-8 C for one-two days. For extended storage, store in -20 C freezer. Working dilution samples should be discarded if not used within 12 hours.
-
-
-
: "Methylglyoxal-induced glycation changes adipose tissue vascular architecture, flow and expansion, leading to insulin resistance." in: Scientific reports, Vol. 7, Issue 1, pp. 1698, (2018) (PubMed).
-
: "Methylglyoxal-induced glycation changes adipose tissue vascular architecture, flow and expansion, leading to insulin resistance." in: Scientific reports, Vol. 7, Issue 1, pp. 1698, (2018) (PubMed).
-
- VEGFA (Vascular Endothelial Growth Factor A (VEGFA))
-
Andere Bezeichnung
- VEGFA
-
Hintergrund
-
Goat polyclonal to VEGFA. This protein is a member of the PDGF/VEGF growth factor family. It is a glycosylated mitogen that specifically acts on endothelial cells and has various effects such as mediating increased vascular permeability, endothelial cell growth, promoting cell migration, inducing angiogenesis and inhibiting apoptosis.
MVCD1, RP1-261G23.1, VEGF, vascular permeability factor and VPF antibody.
-
Pathways
- RTK Signalweg, Glycosaminoglycan Metabolic Process, Regulation of Cell Size, Tube Formation, Signaling Events mediated by VEGFR1 and VEGFR2, Platelet-derived growth Factor Receptor Signaling, VEGFR1 Specific Signals, VEGF Signaling
Target
-